Nursing Research Module 5
The nurse is preparing healthy research subjects for the first phase of a new drug trial. What information
will be obtained upon the completion of phase I of the trial?
a. The adverse drug effects
b. The risks associated with the drug
c. The optimal dosage range of the drug
d. Comparative efficacy with other similar drugs
c. The optimal dosage range of the drug
A patient is undergoing major surgery and asks the nurse about a living will. He states, "I don't want
anybody making decisions for me. And I don't want to prolong my life." The patient is demonstrating:
a. autonomy
b. beneficence
c. justice
d. veracity
a. autonomy
When caring for an elderly Chinese patient, the nurse recognizes that which of these cultural issues may
influence the care of this patient?
a. radiographs are seen as a break in the soul's integrity
b. hospital diets are interpreted as being healing and healthful
c. the use of heat may be an important practice for this patient
d. Being hospitalized is a source of peach and socialization for this culture
, c. the use of heat may be an important practice for this patient
We have an expert-written solution to this problem!
A patient is being counseled for possible participation in a clinical trial for a new medication. After the
patient meets with the physician, the nurse is asked to obtain the patient's signature on the consent
forms. The nurse knows that his "informed consent" indicates which of the following?
a. Once therapy has begun, the patient cannot withdraw from the clinical trial.
b. The patient has been informed of all potential hazards and benefits of the therapy.
c. The patient has received only the information that will help to make the clinical trial a success.
d. No matter what happens, the patient will not be ale to sue the researchers for damages.
b. The patient has been informed of all potential hazards and benefits of the therapy.
We have an expert-written solution to this problem!
A new drug has been approved for use, and the drug manufacturer has made it available for sale. During
the first 6 months, the FDA receives reports of severe adverse effects that were not discovered during
the testing and considers withdrawing the drug. This illustrates which phase of investigational drug
studies?
a. Phase I
b. Phase II
c. Phase III
d. Phase IV
d. Phase IV
We have an expert-written solution to this problem!
A patient of Japanese descent describes a family trait that manifests frequently: She says that members
of her family often have "strong reactions"after taking certain medications, but her white friends have
The nurse is preparing healthy research subjects for the first phase of a new drug trial. What information
will be obtained upon the completion of phase I of the trial?
a. The adverse drug effects
b. The risks associated with the drug
c. The optimal dosage range of the drug
d. Comparative efficacy with other similar drugs
c. The optimal dosage range of the drug
A patient is undergoing major surgery and asks the nurse about a living will. He states, "I don't want
anybody making decisions for me. And I don't want to prolong my life." The patient is demonstrating:
a. autonomy
b. beneficence
c. justice
d. veracity
a. autonomy
When caring for an elderly Chinese patient, the nurse recognizes that which of these cultural issues may
influence the care of this patient?
a. radiographs are seen as a break in the soul's integrity
b. hospital diets are interpreted as being healing and healthful
c. the use of heat may be an important practice for this patient
d. Being hospitalized is a source of peach and socialization for this culture
, c. the use of heat may be an important practice for this patient
We have an expert-written solution to this problem!
A patient is being counseled for possible participation in a clinical trial for a new medication. After the
patient meets with the physician, the nurse is asked to obtain the patient's signature on the consent
forms. The nurse knows that his "informed consent" indicates which of the following?
a. Once therapy has begun, the patient cannot withdraw from the clinical trial.
b. The patient has been informed of all potential hazards and benefits of the therapy.
c. The patient has received only the information that will help to make the clinical trial a success.
d. No matter what happens, the patient will not be ale to sue the researchers for damages.
b. The patient has been informed of all potential hazards and benefits of the therapy.
We have an expert-written solution to this problem!
A new drug has been approved for use, and the drug manufacturer has made it available for sale. During
the first 6 months, the FDA receives reports of severe adverse effects that were not discovered during
the testing and considers withdrawing the drug. This illustrates which phase of investigational drug
studies?
a. Phase I
b. Phase II
c. Phase III
d. Phase IV
d. Phase IV
We have an expert-written solution to this problem!
A patient of Japanese descent describes a family trait that manifests frequently: She says that members
of her family often have "strong reactions"after taking certain medications, but her white friends have
